OMRIX Biopharmaceuticals Ltd.; est. no. 1603

Description

630 Fifth Avenue, New York, NY, and Brussels, Belgium; manufacturing facility at Ramat Gan (also reported by company as Jerusalem), Israel; also facilities in Fairfax, VA; acquired by Johnson & Johnson Co. (J&J) in Nov. 2008 for ~$438 million.

Related product monographs:

No products with related organizations were found.

Location

New York; Jerusalem NY USA Israel For

Reference Number

1603